Page last updated: 2024-11-12
tris-(8-hydroxyquinoline)aluminum
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
tris-(8-hydroxyquinoline)aluminum: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 16683111 |
| SCHEMBL ID | 1360154 |
| MeSH ID | M0543849 |
Synonyms (23)
| Synonym |
|---|
| aluminium tris(quinolin-8-olate) |
| einecs 218-227-0 |
| AKOS002375054 |
| unii-6dp9l7516l |
| tris-(8-hydroxyquinoline)aluminum, 99.995% trace metals basis |
| tris-(8-hydroxyquinoline)aluminum, 98% trace metals basis |
| alq3 |
| 2085-33-8 |
| aluminum 8-hydroxyquinolinate |
| tris-(8-hydroxyquinoline)aluminum |
| tris(8-hydroxyquinolinato)aluminium |
| FT-0602029 |
| SCHEMBL1360154 |
| tris(quinolin-8-yloxy)aluminum |
| tris-(8-hydroxyquinoline)aluminum, sublimed grade, 99.995% trace metals basis |
| mfcd00191693 |
| tris-(8-hydroxyquinoline)aluminum, >99%(hplc), sublimed |
| tris-(8-hydroxyquinoline)aluminum, 98% |
| tri(quinolin-8-yloxy)alumane |
| tris(8-quinolinolato)aluminum (purified by sublimation) |
| aluminium oxinate sputtering target |
| D92587 |
| DTXSID201027201 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (12)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 34.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (34.56) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||